Biotechnology · Healthcare
Board Member
2019-01-01–present
Board Member
Praxis Precision Medicines, Inc. (PRAX)Equibles does not estimate personal net worth.
Get an email with a short summary when Royalty Pharma plc publishes a filing, an earnings call transcript or a press release.
Get RPRX alertsGregory Norden is recorded as CFO at Royalty Pharma plc (RPRX) and Board Member at Praxis Precision Medicines, Inc. (PRAX) since January 1, 2019. The newest filing on record that lists Gregory Norden as CFO at Royalty Pharma plc (RPRX) is dated April 10, 2026. The newest filing on record that lists Gregory Norden as Board Member at Praxis Precision Medicines, Inc. (PRAX) is dated April 30, 2026. Praxis Precision Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Royalty Pharma plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Praxis Precision Medicines, Inc. includes Marcio Souza (CEO and Board Member), Timothy E. Kelly (CFO), Timothy Kelly (CFO) and 6 others.
2019-01-01–present
Last confirmed April 30, 2026
Start not stated–present
Last confirmed April 10, 2026
Biotechnology · Healthcare
Board Member
2019-01-01–present
No call appearances or filed executive changes recorded yet.